>> Abbot Laboratories
The third largest Fortune 500 pharmaceutical company “discovers, develops, manufactures and sells pharmaceutical and nutritional products such as drug delivery systems, antibiotics and prepared infant formulas.” These include Similac for infants, products for people with HIV, and specialized surgical devices for patients with vascular disease. Abbot had revenues of $31 billion last year.
Website:
http://www.abbott.com/
>> Allergan
Allergan, Inc. is a diversified healthcare company. It focuses on developing and making products that deal with medical aesthetics, eye care, medical dermatology, obesity intervention, neurosciences, and urologics, among other areas. More than 50 percent of the Irvine, California-based $4.5 billion company’s workforce works in research and development.
Website:
http://www.allergan.com/ >> Amgen
For more than 25 years, Amgen, the Thousand Oaks, California, $14.6 billion company has been a leader in the human therapeutics area of biotechnology. It led the development of products based on recombinant DNA and molecular biology and created medicines to treat cancer, kidney disease, and rheumatoid arthritis.
Website:
http://www.amgen.com/
by Frank McCoy,
fmccoy@ccgmag.com >> Gilead Sciences >> Genzyme
Founded in 1981, the Cambridge, Massachusetts firm specializes in developing products to treat “rare inherited disorders, kidney disease, orthopedics, transplant and immune disease, cancer, and diagnostic testing.” Its 2009 revenues were $4.5 billion.
Website:
http://www.genzyme.com/
Since 1987, Gilead has discovered and developed, made and marketed biopharmaceutical therapies to battle cancer, as well as infectious and viral diseases. The Foster City, California, company has 4,000 employees. Its primary interests include treatments for HIV/AIDS, liver disease, as well as cardiovascular and respiratory conditions. Gilead had revenues of $7 billion in 2009.
Website:
http://www.gilead.com/ >> Johnson & Johnson
The Brunswick, New Jersey firm, and the largest of the Fortune 500 pharmaceutical companies, makes prescription and consumer products, medical devices and diagnostics. These include everything from Concerta for people with attention deficit disorder to Band-Aids, and even spine and joint implants. J&J manages 250 operating companies in 57 countries that employ about 114,000 people. The company made $62 billion in 2009.
Website:
http://www.jnj.com/
96 USBE&IT I WINTER 2011
www.blackengineer.com
Dynamic D Big
The
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136